tiprankstipranks
Advertisement
Advertisement

JP:4599 Stock Latest News

StemRIM Unveils Midterm FY2026 Results and R&D Progress in Regenerative Medicine
Company AnnouncementsStemRIM Unveils Midterm FY2026 Results and R&D Progress in Regenerative Medicine
22d ago
4599
StemRIM narrows interim loss as it ramps R&D on regenerative drug pipeline
PremiumCompany Announcements
StemRIM narrows interim loss as it ramps R&D on regenerative drug pipeline
24d ago
4599
StemRIM Wins Key Patent on Gene Therapy SR-GT1 for Dystrophic Epidermolysis Bullosa
PremiumCompany Announcements
StemRIM Wins Key Patent on Gene Therapy SR-GT1 for Dystrophic Epidermolysis Bullosa
1M ago
4599
StemRIM Wins Canadian Patent for Redasemtide Use in Cartilage Disorders
PremiumCompany Announcements
StemRIM Wins Canadian Patent for Redasemtide Use in Cartilage Disorders
2M ago
4599
StemRIM Completes Global Phase 2b Enrollment for Stroke Drug Redasemtide
PremiumCompany Announcements
StemRIM Completes Global Phase 2b Enrollment for Stroke Drug Redasemtide
3M ago
4599
StemRIM Secures Patent for Innovative Fatty Liver and NASH Therapy in Japan
PremiumCompany AnnouncementsStemRIM Secures Patent for Innovative Fatty Liver and NASH Therapy in Japan
4M ago
4599
StemRIM Inc. Reports Q3 2025 Financial Results Amid Ongoing R&D Investments
Premium
Company Announcements
StemRIM Inc. Reports Q3 2025 Financial Results Amid Ongoing R&D Investments
4M ago
4599
StemRIM Completes New Share Issuance for Stock Compensation
Premium
Company Announcements
StemRIM Completes New Share Issuance for Stock Compensation
4M ago
4599
StemRIM Inc. Forms Voluntary Compensation Committee to Enhance Governance
PremiumCompany Announcements
StemRIM Inc. Forms Voluntary Compensation Committee to Enhance Governance
4M ago
4599
StemRIM Inc. Unveils Revolutionary Regenerative Medicine Plan
PremiumCompany Announcements
StemRIM Inc. Unveils Revolutionary Regenerative Medicine Plan
4M ago
4599
StemRIM Inc. Issues New Shares for Restricted Stock Remuneration
PremiumCompany Announcements
StemRIM Inc. Issues New Shares for Restricted Stock Remuneration
5M ago
4599
StemRIM Secures Patent for Innovative Gene Therapy Targeting Skin Disorder
PremiumCompany Announcements
StemRIM Secures Patent for Innovative Gene Therapy Targeting Skin Disorder
6M ago
4599
StemRIM Secures US Patent for Psoriasis Treatment
PremiumCompany AnnouncementsStemRIM Secures US Patent for Psoriasis Treatment
6M ago
4599
StemRIM Inc. Issues Stock Options to Enhance Stakeholder Engagement
Premium
Company Announcements
StemRIM Inc. Issues Stock Options to Enhance Stakeholder Engagement
6M ago
4599
StemRIM Inc. Proposes Stock Options to Boost Workforce Morale
Premium
Company Announcements
StemRIM Inc. Proposes Stock Options to Boost Workforce Morale
7M ago
4599
StemRIM Inc. Reports Fiscal Year 2025 Financial Results and Strategic Progress
PremiumCompany Announcements
StemRIM Inc. Reports Fiscal Year 2025 Financial Results and Strategic Progress
7M ago
4599
StemRIM Inc. Announces Stock Options for Directors
PremiumCompany Announcements
StemRIM Inc. Announces Stock Options for Directors
7M ago
4599
StemRIM Inc. Issues Stock Options to Employees
PremiumCompany Announcements
StemRIM Inc. Issues Stock Options to Employees
7M ago
4599
StemRIM Inc. Issues Stock Options to Boost R&D and Shareholder Value
PremiumCompany Announcements
StemRIM Inc. Issues Stock Options to Boost R&D and Shareholder Value
7M ago
4599
StemRIM Inc. Issues Stock Options to Enhance Employee Motivation and Company Value
PremiumCompany AnnouncementsStemRIM Inc. Issues Stock Options to Enhance Employee Motivation and Company Value
7M ago
4599
StemRIM Inc. Issues Stock Options to Directors
Premium
Company Announcements
StemRIM Inc. Issues Stock Options to Directors
7M ago
4599
StemRIM Inc. Reports Financial Results and Future Outlook
Premium
Company Announcements
StemRIM Inc. Reports Financial Results and Future Outlook
7M ago
4599

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >